Three novel mutations in Iranian patients with Tay-Sachs disease

Iran Biomed J. 2014;18(2):114-9. doi: 10.6091/ibj.1137.2013.

Abstract

Background: Tay-Sachs disease (TSD), or GM2 gangliosidosis, is a lethal autosomal recessive neurodegenerative disorder, which is caused by a deficiency of beta-hexosaminidase A (HEXA), resulting in lysosomal accumulation of GM2 ganglioside. The aim of this study was to identify the TSD-causing mutations in an Iranian population.

Methods: In this study, we examined 31 patients for TSD-causing mutations using PCR, followed by restriction enzyme digestion.

Results: Molecular genetics analysis of DNA from 23 patients of TSD revealed mutations that has been previously reported, including four-base duplications c.1274_1277dupTATC in exon 11 and IVS2+1G>A, deletion TTAGGCAAGGGC in exon 10 as well as a few novel mutations, including C331G, which altered Gln>Glu in HEXB, A>G, T>C, and p.R510X in exon 14, which predicted a termination codon or nonsense mutation.

Conclusion: In conclusion, with the discovery of these novel mutations, the genotypic spectrum of Iranian patients with TSD disease has been extended and could facilitate definition of disease-related mutations.

Keywords: Tay-Sachs disease; β- hexosaminidase A; β- hexosaminidase B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Iran / epidemiology
  • Mutation / genetics*
  • Protein Subunits / genetics
  • Tay-Sachs Disease / diagnosis*
  • Tay-Sachs Disease / epidemiology
  • Tay-Sachs Disease / genetics*
  • beta-Hexosaminidase alpha Chain / genetics*
  • beta-Hexosaminidase beta Chain / genetics

Substances

  • Protein Subunits
  • HEXA protein, human
  • HEXB protein, human
  • beta-Hexosaminidase alpha Chain
  • beta-Hexosaminidase beta Chain